Consistency of state statutes with the centers for disease control and prevention HIV testing recommendations for health care settings

Annals of Internal Medicine

Volumn 150, Issue 4, 2009, Pages 263-269

  Mahajan, Anish P ^a   Stemple, Lara ^b   Shapiro, Martin F ^a   King, Jan B ^c   Cunningham, William E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Office of AIDS Programs and Policies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COUNSELING; DISEASE CONTROL; HEALTH CARE; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS; LAW; PRACTICE GUIDELINE; PREVENTION AND CONTROL; PRIORITY JOURNAL; SCREENING; UNITED STATES;

EID: 60849102805     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-150-4-200902170-00007     Document Type: Article

References (87)

1. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al; Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1-17; quiz CE1-4. [PMID: 16988643]
2. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States, 2004. HIV/AIDS Surveillance Rep. 2005;16:16-45.
3. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission ofHIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447-50. [PMID: 16791020]
4. Centers for Disease Control and Prevention (CDC). Number of persons tested for HIV-United States, 2002. MMWR Morb Mortal Wkly Rep. 2004; 53:1110-3. [PMID: 15573028]
5. Beckwith CG, Flanigan TP, del Rio C, Simmons E, Wing EJ, Carpenter CC, et al. It is time to implement routine, not risk-based, HIV testing. Clin Infect Dis. 2005;40:1037-40. [PMID: 15824997]
6. Burke RC, Sepkowitz KA, Bernstein KT, Karpati AM, Myers JE, Tsoi BW, et al. Why don't physicians test for HIV? A review of the US literature. AIDS. 2007;21:1617-24. [PMID: 17630557]
7. Worthington C, Myers T. Factors underlying anxiety in HIV testing: risk perceptions, stigma, and the patient-provider power dynamic. Qual Health Res. 2003;13:636-55. [PMID: 12756685]
8. Liddicoat RV, Horton NJ, Urban R, Maier E, Christiansen D, Samet JH. Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med. 2004;19:349-56. [PMID: 15061744]
9. Centers for Disease Control and Prevention (CDC). Missed opportunities for earlier diagnosis of HIV infection-South Carolina, 1997-2005. MMWR Morb Mortal Wkly Rep. 2006;55:1269-72. [PMID: 17136020]
10. Centers for Disease Control and Prevention. Revised recommendations for HIV screening of pregnant women. MMWR Recomm Rep. 2001;50:63-85;quizCE1-19a2-CE6-19a2. [PMID: 11718473]
11. HIV activists tell New York Department of Health to stop gutting informed consent laws. New York: American Civil Liberties Union; 15 May 2006. Accessed at www.aclu.org/hiv/privacy/25557prs20060515.html on 1 November 2008.
12. Holtgrave DR. Costs and consequences of the U.S. Centers for Disease Control and Prevention's recommendations for opt-out HIV testing. PLoS Med. 2007;4:e194. [PMID: 17564488]
13. Tarantola D, Gruskin S. New guidance on recommended HIV testing and counselling. Lancet. 2007;370:202-3. [PMID: 17658377]
14. Goldman J, Kinnear S, Chung J, Rothman DJ. New York City's initiatives on diabetes and HIV/AIDS: implications for patient care, public health, and medical professionalism. Am J Public Health. 2008;98:807-13. [PMID: 18381989]
15. WolfLE, Donoghoe A, Lane T. Implementing routine HIV testing: the role of state law. PLoS ONE. 2007;2:e1005. [PMID: 17925853]
16. Bartlett JG, Branson BM, Fenton K, Hauschild BC, Miller V, Mayer KH. Opt-out testing for human immunodeficiency virus in the United States: progress and challenges. JAMA. 2008;300:945-51. [PMID: 18728268]
17. Hanssens C. Legal and ethical implications of opt-out HIV testing. Clin Infect Dis. 2007;45 Suppl 4:S232-9. [PMID: 18190292]
18. Ariz. Rev. Stat. § 36-663 (2008).
19. Cal. Health and Safety Code § 120990 (2008).
20. 410 Ill. Comp. Stat. 305/4 and 305/5 (2008).
21. La. Rev. Stat. Ann. § 40:1300.13 (2008).
22. Md. Code Ann., Health-Gen. § 18-336 (2008).
23. Me. Rev. Stat. Ann. tit. 5 § 19203-A (2008).
24. N.H. Rev. Stat. Ann. § 141-F:5 (2008).
25. N.M. Stat. Ann. § 24-2B-2 (2008).
26. Va. Code Ann. § 32.1-37.2 (2008).
27. Iowa Code § 141A.6 (2008).
28. Ky. Rev. Stat. Ann. § 214.181 (2008).
29. Tex. Code Ann. § 81.105/6 (2008).
30. Ala. Code § 22-11A-51 (2008).
31. Haw. Rev. Stat. § 325-16 (2008).
32. Mass. Gen. Laws 111 § 70F (2008).
33. Mich. Comp. Laws § 333.5133 (2008).
34. Neb. Rev. Stat. § 71-531 (2008).
35. N.Y. Pub. Health Law § 2781 (2008).
36. 35 Pa. Cons. Stat. § 7605 (2008).
37. R.I. Gen. Laws § 23-6-12/13, § 23-17-31 (2008).
38. Wis. Stat. § 252.15 (2008).
39. Conn. Gen. Stat. § 19a-582 (2008).
40. Del. Code Ann. tit. 16 § 1202 (2008).
41. Fla. Stat. § 381.004 (2008).
42. Ind. Code § 16-41-6-1 (2008).
43. Mont. Code Ann. § 50-16-1003/7 (2008).
44. Ohio Rev. Code Ann. § 3701.242 (2008).
45. W. Va. Code § 16-3C-2 (2008).
46. Colo. Rev. Stat. § 25-4-1405 (2008).
47. Mo. Rev. Stat. § 191.653 (2008).
48. Or. Rev. Stat. § 433.045, § 677.097 (2008).
49. Wash. Rev. Code § 70.24.330 (2008).
50. Ga. Code Ann. § 31-22-9.1/2 (2008).
51. N.H. Rev. Stat. Ann. § 141-F:7 (2008).
52. R.I. Gen. Laws § 23-11-17, § 23-17-31 (2008).
53. Wis. Stat. § 252.14 (2008).
54. Ark. Code Ann. § 20-16-507 (2008).
55. Cal. Health and Safety Code § 125090/125107 (2008).
56. Fla. Stat. § 384.31 (2008).
57. Ga. Code Ann. § 31-17-4.2 (2008).
58. Iowa Code § 141A.4 (2008).
59. 410 Ill. Comp. Stat. § 335/10 (2008).
60. La. Rev. Stat. Ann. § 40:1091 (2008).
61. Md. Code Ann., Health-Gen. § 18-338.2 (2008).
62. N.J. Stat. Ann. § 26:5C-16 (2008).
63. R.I. Gen. Laws § 23-13-19 (2008).
64. Tenn. Code Ann. § 68-5-703 (2008).
65. Tex. Code Ann. § 81.090 (2008).
66. Va. Code Ann. § 54.1-2403.01 (2008).
67. Mich. Comp. Laws § 333.5123 (2008).
68. Or. Rev. Stat. § 433.017 (2008).
69. Conn. Gen. Stat. § 19a-593 (2008).
70. Ind. Code § 16-41-6-7/8 (2008).
71. Del. Code Ann. tit. 16, § 1204 (2008).
72. Ind. Code § 16-41-6-6 (2008).
73. National HIV/AIDS Clinician's Consultation Center. State HIV Testing Laws Compendium. San Francisco: University of California, San Francisco; 2007. Accessed at www.nccc.ucsf.edu/StateLaws/Index.html on 1 November 2008.
74. Lyons MS, Lindsell CJ, Fichtenbaum CJ, Camargo CA Jr. Interpreting and implementing the 2006 CDC recommendations for HIV testing in health-care settings. Public Health Rep. 2007;122:579-83. [PMID: 17877304]
75. Garner BA, Campbell Black H. Black's Law Dictionary. 8th ed. St. Paul, MN: Thomson/West, 2006.
76. Brown J, Shesser R, Simon G, Bahn M, Czarnogorski M, Kuo I, et al. Routine HIV screening in the emergency department using the new US Centers for Disease Control and Prevention Guidelines: results from a high-prevalence area. J Acquir Immune Defic Syndr. 2007;46:395-401. [PMID: 18077831]
77. Mahajan AP, Sayles JN, Patel VA, Remien RH, Sawires SR, Ortiz DJ, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS. 2008;22 Suppl 2:S67-79. [PMID: 18641472]
78. Haukoos JS, Hopkins E, Byyny RL; Denver Emergency Department HIV Testing Study Group. Patient acceptance of rapid HIV testing practices in an urban emergency department: assessment of the 2006 CDC recommendations for HIV screening in health care settings. Ann Emerg Med. 2008;51:303-9, 309.e1. [PMID: 18191295]
79. Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, et al; HIV Incidence Surveillance Group. Estimation of HIV incidence in the United States. JAMA. 2008;300:520-9. [PMID: 18677024]
80. Centers for Disease Control and Prevention (CDC). Late versus earlytesting of HIV-16 Sites, United States, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;52:581-6. [PMID: 12836626]
81. Keruly JC, Moore RD. Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006. Clin Infect Dis. 2007;45:1369-74. [PMID: 17968837]
82. Garcia F, de Lazzari E, Plana M, Castro P, Mestre G, Nomdedeu M, et al. Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. J Acquir Immune Defic Syndr. 2004;36: 702-13. [PMID: 15167289]
83. Moore RD, Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007;44:441-6. [PMID: 17205456]
84. Kaiser Family Foundation. SurveyofAmericans on HIV/AIDS. Menlo Park, CA: Kaiser Family Foundation; 2006. Accessed at www.kff.org/kaiserpolls/ pomr050806pkg.cfm on 1 November 2008.
85. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, et al. Expanded screening for HIV in the United States-an analysis of cost-effectiveness. N Engl J Med. 2005;352:586-95. [PMID: 15703423]
86. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352:570-85. [PMID: 15703422]
87. Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, Weinstein MC, et al. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med. 2006;145: 797-806. [PMID: 17146064]